Figure 4.
Severity of ocular symptoms at baseline (preserved latanoprost) and 12 weeks after changing medication to preservative-free tafluprost evaluated by using the OSDI questionnaire.
Abbreviation: OSDI, Ocular Surface Disease Index.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.